Observations placeholder
Amaryl
Identifier
015643
Type of Spiritual Experience
Background
A description of the experience
Glimepiride is a medium- to long-acting sulfonylurea antidiabetic drug. It is marketed as GLEAM by Franco Indian Pharmaceuticals,K-GLIM-1 by BLUE CROSS, Glucoryl by Alkem Lab PVT LTD , Amaryl by Sanofi-Aventis, GLIMPID by Ranbaxy Laboratories(Cardiovascular) and GLIMY by Dr.Reddy's Labs.
On Dec, 21, 2016 26,136 people reported to have side effects when taking Amaryl.
Among them, 91 people (0.35%) have Hallucination
Time on Amaryl when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 54.55% | 27.27% | 18.18% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Amaryl :
Female | Male | |
Hallucination | 64.13% | 35.87% |
Age of people who have Hallucination when taking Amaryl :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 1.27% | 7.59% | 11.39% | 79.75% |